Posaconazole Delayed Release Oral Tablet

DRUG2 trials

Sponsors

Cedars-Sinai Medical Center, Post Graduate Institute of Medical Education and Research, Chandigarh

Conditions

CARD9 S12N Risk AlleleChronic Pulmonary AspergillosisCrohn Disease

Phase 3

A Study of Itraconazole and Posaconazole for Chronic Pulmonary Aspergillosis

Not yet recruitingNCT07825259

Post Graduate Institute of Medical Education and Research, ChandigarhChronic Pulmonary Aspergillosis

Start: 2026-11-01End: 2029-12-31Target: 220Updated: 2026-09-17

Phase 4

Pilot Study of Posaconazole in Crohn's Disease

TerminatedNCT04966585

Cedars-Sinai Medical CenterCARD9 S12N Risk Allele, Crohn Disease

Start: 2022-08-17End: 2025-01-22Updated: 2026-02-24